Abstract
Berberine, a fluorescent, aromatic, heterocyclic alkaloid, produced in a diversity of plants, was found to have curative properties in Chinese herbal medicine. Berberine is used as a treatment for gastric and inflammatory diseases and as an antimicrobial agent. More recently the potential of this alkaloid in diverse new medical application like cardiology, neurology and oncology is being investigated. As a result of its fluorescent properties, it has also been used in chemistry to study protein conformation and protein/protein interactions and to quantitate non-fluorescent compounds. All these applications will be summarized and discussed in this review.
Keywords: Berberine, fluorescent, alkaloid, analysis, medicine, biochemistry
Mini-Reviews in Organic Chemistry
Title: Berberine: A Fluorescent Alkaloid with a Variety of Applications from Medicine to Chemistry
Volume: 7 Issue: 4
Author(s): M. P. Domingo, J. Pardo, V. Cebolla and Eva M. Galvez
Affiliation:
Keywords: Berberine, fluorescent, alkaloid, analysis, medicine, biochemistry
Abstract: Berberine, a fluorescent, aromatic, heterocyclic alkaloid, produced in a diversity of plants, was found to have curative properties in Chinese herbal medicine. Berberine is used as a treatment for gastric and inflammatory diseases and as an antimicrobial agent. More recently the potential of this alkaloid in diverse new medical application like cardiology, neurology and oncology is being investigated. As a result of its fluorescent properties, it has also been used in chemistry to study protein conformation and protein/protein interactions and to quantitate non-fluorescent compounds. All these applications will be summarized and discussed in this review.
Export Options
About this article
Cite this article as:
P. Domingo M., Pardo J., Cebolla V. and M. Galvez Eva, Berberine: A Fluorescent Alkaloid with a Variety of Applications from Medicine to Chemistry, Mini-Reviews in Organic Chemistry 2010; 7 (4) . https://dx.doi.org/10.2174/157019310792246445
DOI https://dx.doi.org/10.2174/157019310792246445 |
Print ISSN 1570-193X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6298 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
PLK1 Inhibition: Prospective Role for the Treatment of Pediatric Tumors
Current Drug Targets The Molecular Pathology of Eye Tumors: A 2019 Update Main Interests for Routine Clinical Practice
Current Molecular Medicine The Interaction Between FAK, MYCN, p53 and Mdm2 in Neuroblastoma
Anti-Cancer Agents in Medicinal Chemistry Therapeutically Targeting MicroRNAs in Liver Cancer
Current Pharmaceutical Design Metallothionein as a Scavenger of Free Radicals - New Cardioprotective Therapeutic Agent or Initiator of Tumor Chemoresistance?
Current Drug Targets Therapies of Hematological Malignancies: An Overview of the Potential Targets and Their Inhibitors
Current Chemical Biology Mechanisms of Resistance to Photodynamic Therapy
Current Medicinal Chemistry Effectiveness of Two Novel Anionic and Cationic Platinum Complexes in the Treatment of Osteosarcoma
Anti-Cancer Agents in Medicinal Chemistry Camptothecins and Lung Cancer: Improved Delivery Systems by Aerosol
Current Cancer Drug Targets The Role of Proteomics in Osteoarthritis Pathogenesis Research
Current Drug Targets Hypoxic Regulation of Metastasis via Hypoxia-Inducible Factors
Current Molecular Medicine Traditional Chinese Medicine Remedy to Jury: The Pharmacological Basis for the Use of Shikonin as an Anticancer Therapy
Current Medicinal Chemistry From 2D to 3D - a New Dimension for Modelling the Effect of Natural Products on Human Tissue
Current Pharmaceutical Design Thermodynamic and Kinetic Aspects Involved in the Development of Nanocarriers and Drug Delivery Systems Based on Cationic Biopolymers
Current Pharmaceutical Design Developments of Polo-like Kinase 1 (Plk1) Inhibitors as Anti-Cancer Agents
Mini-Reviews in Medicinal Chemistry Phytochemical-Mediated Glioma Targeted Treatment: Drug Resistance and Novel Delivery Systems
Current Medicinal Chemistry Osteoinductive Small Molecules: Growth Factor Alternatives for Bone Tissue Engineering
Current Pharmaceutical Design Src Inhibitors and Angiogenesis
Current Pharmaceutical Design Cardiac (myo)fibroblast: Novel Strategies for its Targeting Following Myocardial Infarction
Current Pharmaceutical Design Developments in the Application of 1,2,3-Triazoles in Cancer Treatment
Recent Patents on Anti-Cancer Drug Discovery